These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

594 related items for PubMed ID: 8413475

  • 21. Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33-35 completed weeks' gestational age in Canada.
    Paes B, Steele S, Janes M, Pinelli J.
    Curr Med Res Opin; 2009 Jul; 25(7):1585-91. PubMed ID: 19469698
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children.
    Simoes EA, Groothuis JR, Tristram DA, Allessi K, Lehr MV, Siber GR, Welliver RC.
    J Pediatr; 1996 Aug; 129(2):214-9. PubMed ID: 8765618
    [Abstract] [Full Text] [Related]

  • 24. Prophylaxis in RSV infection (Palivizumab)--is it worthwhile?
    Hashmi NA, Cosgrove JF, MacMahon P.
    Ir Med J; 2000 Dec; 93(9):284. PubMed ID: 11209917
    [Abstract] [Full Text] [Related]

  • 25. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia.
    Groothuis JR, Gutierrez KM, Lauer BA.
    Pediatrics; 1988 Aug; 82(2):199-203. PubMed ID: 3399292
    [Abstract] [Full Text] [Related]

  • 26. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
    Simoes EA, Carbonell-Estrany X.
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Immunoglobulin for preventing respiratory syncytial virus infection.
    Wang EE, Tang NK.
    Cochrane Database Syst Rev; 2000 Feb; (2):CD001725. PubMed ID: 10796658
    [Abstract] [Full Text] [Related]

  • 30. The severity of respiratory syncytial virus bronchiolitis in young infants in the United Arab Emirates.
    Howidi M, Rajah J, Abushrar Z, Parsons H.
    J Trop Pediatr; 2007 Feb; 53(1):22-6. PubMed ID: 17008442
    [Abstract] [Full Text] [Related]

  • 31. Prevention of respiratory syncytial virus infection among Puerto Rican infants.
    Winchester L, García L, García I, Concepción CB.
    P R Health Sci J; 2002 Sep; 21(3):191-3. PubMed ID: 12243108
    [Abstract] [Full Text] [Related]

  • 32. [Humanized respiratory syncytial virus monoclonal antibody].
    Tsutsumi H.
    Nihon Rinsho; 2002 Mar; 60(3):487-91. PubMed ID: 11904963
    [Abstract] [Full Text] [Related]

  • 33. Prophylaxis for respiratory syncytial virus with respiratory syncytial virus-immunoglobulin intravenous among preterm infants of thirty-two weeks gestation and less: reduction in incidence, severity of illness and cost.
    Atkins JT, Karimi P, Morris BH, McDavid G, Shim S.
    Pediatr Infect Dis J; 2000 Feb; 19(2):138-43. PubMed ID: 10694001
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Rates of hospitalization for respiratory syncytial virus infection among children in medicaid.
    Boyce TG, Mellen BG, Mitchel EF, Wright PF, Griffin MR.
    J Pediatr; 2000 Dec; 137(6):865-70. PubMed ID: 11113845
    [Abstract] [Full Text] [Related]

  • 36. From the American Academy of Pediatrics: Policy statements--Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections.
    Committee on Infectious Diseases.
    Pediatrics; 2009 Dec; 124(6):1694-701. PubMed ID: 19736258
    [Abstract] [Full Text] [Related]

  • 37. Predictive value of the respiratory syncytial virus risk-scoring tool in the term infant in Canada.
    Paes B, Cole M, Latchman A, Pinelli J.
    Curr Med Res Opin; 2009 Sep; 25(9):2191-6. PubMed ID: 19604126
    [Abstract] [Full Text] [Related]

  • 38. Impact of palivizumab prophylaxis on respiratory syncytial virus hospitalizations in high risk Alaska Native infants.
    Singleton R, Dooley L, Bruden D, Raelson S, Butler JC.
    Pediatr Infect Dis J; 2003 Jun; 22(6):540-5. PubMed ID: 12799511
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Respiratory syncytial virus infections in children admitted to the intensive care unit.
    Van Steensel-Moll HA, Van der Voort E, Bos AP, Rothbarth PH, Neijens HJ.
    Pediatrie; 1989 Jun; 44(7):583-8. PubMed ID: 2812976
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.